Browsing: Wellness Tips

Backed by a £5million marketing investment from new owner Supreme, SlimFast has been remodeled into a ‘trusted everyday nutrition solution’ to support the growing number of shoppers who are looking to support protein intake, digestive health, hydration, recovery and healthy aging, alongside weight management

Rosie O’Donnell names weightloss drug that made her feel ‘better’ at 64   Entertainment

Eli Lilly’s Foundayo is the second oral weight-loss pill to be approved in Europe, after U.K. approval. On Monday, the U.K.’s Medicines and Healthcare products regulatory agency announced approval of orforglipron, to be marketed as Foundayo, for helping patients lose weight and manage type 2 diabetes. But there’s a catch for British patients: the drug…

When one sees Virat Kohli, an Indian cricketer, be it at international level or domestic or even at club level, cannot help but marvel at his physique and fitness. While Kohli took the hard route by changing his diet, some players, even at IPL level, may be looking for a shortcut

Rosie O’Donnell said the early weight loss she experienced on Mounjaro frightened her so much that she thought she had cancer

Leslie Jones turned heads on the red carpet at Copenhagen Fashion Week, where she posed in a waist-cinching dress that showed off her impressive weight-loss progress

Doctors are now warning of a possible correlation between rapid weight loss and a condition that can make it difficult to lift or move your foot. (WSBT FILE photo)

Eli Lilly (NYSE:LLY) has secured U.K. approval for its once-daily weight-loss pill Foundayo, giving the drugmaker its first regulatory win for the treatment outside the U.S. and escalating its obesity battle with Novo Nordisk. The approval expands Lilly’s opportunity beyond injectable drugs such as Zepbound while giving patients a potentially simpler oral option in one…

Hims & Hers Health (HIMS) was in focus on Tuesday following a wave of Wall Street action after its second-quarter results, with Citi warning that the company faces heightened execution risk as its full-year outlook requires a “hefty” increase in fourth-quarter earnings before interest, tax, depreciation and amortization

Gut microbiomes may be an overlooked puzzle piece in the ‘thrifty gene hypothesis,’ ASU researcher says